Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

High-Throughput Screening to Develop a Biologically Relevant Netosis Induction Model

Sunday, December 10, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The poster titled 'High-Throughput Screening to Develop a Biologically Relevant Netosis Induction Model' was presented at ASH 2023 by Zukas et al. It highlights advancements in creating a model for netosis induction, which could be significant for understanding related biological processes. The research may contribute to improved methodologies in the field.
Price reaction · baseline $12.734 (2023-12-08 close) · clean, no other VNRX news in the window
day 0 close · peak
-9.2%
day 1
-6.5%
day 3
+7.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation at a prominent conference (ASH 2023)
  • Focus on developing a biologically relevant model
  • High-throughput screening may enhance research efficiency

Full Press Release Details

Poster titled: High-Throughput Screening to Develop a Biologically Relevant Netosis Induction Model
Presented at ASH 2023
Zukas et al

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was presented at ASH 2023?

A poster on developing a biologically relevant netosis induction model.

Who presented the research at ASH 2023?

The research was presented by Zukas et al.

What is the focus of the netosis model?

The model aims to enhance understanding of netosis induction.

What method is used in the netosis model development?

High-throughput screening is utilized for the model development.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare netosis ASH 2023 high-throughput screening biological model
Last updated: Dec 10, 2023

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk